Home Featured Page 218

Featured

Latest

Psychedelic Funding Update: Q3 2025

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Beckley Psytech announces first patient has received low-dose psilocybin in world-first...

Psychedelic Bulletin: COMPASS Pathways Acquires IP Portfolio; Wesana to Explore MDMA...

Amanita muscaria – A Fresh Look at An Iconic Mushroom

PTSF77 – Progress and Context, with Jesse Gould of the Heroic...

Awakn Life Sciences to Acquire Leading Ketamine-Assisted Psychotherapy Clinic in Norway

Former Compass Interim Clinical Sciences Director Joins Clerkenwell Health as CMO

MINDCURE Joins Digital Therapeutics Alliance to Drive Innovation in the Mental...

Awakn Life Sciences Reports Second Quarter 2021 Financial Results and Business...

Nova Mentis Applies to US FDA for Psilocybin Orphan Drug Designation...

Understanding ‘Spiritual Emergency’ in the Context of Psychedelics

1...217218219...299 Page 218 of 299

Psychedelic Funding Update: Q3 2025

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelic Funding Update: Q3 2025

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Beckley Psytech announces first patient has received low-dose psilocybin in world-first...

Psychedelic Bulletin: COMPASS Pathways Acquires IP Portfolio; Wesana to Explore MDMA...

Amanita muscaria – A Fresh Look at An Iconic Mushroom

PTSF77 – Progress and Context, with Jesse Gould of the Heroic...

Awakn Life Sciences to Acquire Leading Ketamine-Assisted Psychotherapy Clinic in Norway

Former Compass Interim Clinical Sciences Director Joins Clerkenwell Health as CMO

MINDCURE Joins Digital Therapeutics Alliance to Drive Innovation in the Mental...

Awakn Life Sciences Reports Second Quarter 2021 Financial Results and Business...

Nova Mentis Applies to US FDA for Psilocybin Orphan Drug Designation...

Understanding ‘Spiritual Emergency’ in the Context of Psychedelics

EDITOR PICKS

Psychedelic Funding Update: Q3 2025

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY